PLG and hemorrhage: Tranexamic acid (TXA) is a lysine-analog antifibrinolytic agent that inhibits fibrinolysis by reversibly binding to lysine receptor sites on plasminogen and plasmin, thereby disrupting their interaction with fibrin.7-10 This drug is considered potentially useful for managing intracranial hemorrhages secondary to TBI.